Strategic EP, LLC Discloses New 5.1% Stake in Lixte Biotechnology Holdings, Inc.

On June 9, 2026, Strategic EP, LLC and Alexander Chase Deitch filed a Schedule 13G disclosing a new 5.1% ownership stake in Lixte Biotechnology Holdings, Inc. (LIXT). The reporting persons collectively hold 774,902 shares of common stock, which were acquired as of the event date on June 4, 2026. Strategic EP, LLC, a Delaware limited liability company, and Mr. Deitch, its manager, share voting and dispositive power over these shares. Additionally, the reporting persons hold warrants for an additional 545,521 shares; however, these warrants contain a blocker provision preventing exercise if it would result in beneficial ownership exceeding 4.99%, and thus are not included in the current beneficial ownership total. The filing indicates that the securities were acquired for investment purposes and not with the intent to influence or change the control of the issuer. This filing marks a significant new position for the reporting persons in the Boca Raton-based biotechnology company.